347 related articles for article (PubMed ID: 30137524)
1. Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.
Hoskin JL; Al-Hasan Y; Sabbagh MN
Nicotine Tob Res; 2019 Feb; 21(3):370-376. PubMed ID: 30137524
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
3. Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.
Russo P; Del Bufalo A; Frustaci A; Fini M; Cesario A
Curr Pharm Des; 2014; 20(38):6014-21. PubMed ID: 24641224
[TBL] [Abstract][Full Text] [Related]
4. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
Beinat C; Banister SD; Herrera M; Law V; Kassiou M
CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
[TBL] [Abstract][Full Text] [Related]
6. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron and its targets in Alzheimer's disease.
Hashimoto K
Expert Opin Ther Targets; 2015 Jan; 19(1):1-5. PubMed ID: 25399811
[TBL] [Abstract][Full Text] [Related]
8. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.
Wang XL; Deng YX; Gao YM; Dong YT; Wang F; Guan ZZ; Hong W; Qi XL
Aging (Albany NY); 2020 Jan; 12(1):543-570. PubMed ID: 31905173
[TBL] [Abstract][Full Text] [Related]
9. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
Ma KG; Qian YH
Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
Farhat SM; Ahmed T
Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β overproducing transgenic mice.
Stoiljkovic M; Kelley C; Hajós GP; Nagy D; Koenig G; Leventhal L; Hajós M
Neurobiol Aging; 2016 Sep; 45():161-168. PubMed ID: 27459936
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations.
Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M
Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
Verma S; Kumar A; Tripathi T; Kumar A
J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
[TBL] [Abstract][Full Text] [Related]
15. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
17. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
18. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
Oz M; Lorke DE; Yang KH; Petroianu G
Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.
Chen SG; Gu RX; Dai H; Wei DQ
J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879
[TBL] [Abstract][Full Text] [Related]
20. Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease.
Echeverria V; Yarkov A; Aliev G
Prog Neurobiol; 2016 Sep; 144():142-57. PubMed ID: 26797042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
